0000899243-18-008417.txt : 20180322 0000899243-18-008417.hdr.sgml : 20180322 20180322213651 ACCESSION NUMBER: 0000899243-18-008417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180320 FILED AS OF DATE: 20180322 DATE AS OF CHANGE: 20180322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRACHMAN JONATHAN G CENTRAL INDEX KEY: 0001588467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 18708237 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-20 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001588467 DRACHMAN JONATHAN G 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 See Remarks Non-qualified Stock Option (Right to buy) 34.20 2018-03-20 4 A 0 10526 0.00 A 2026-05-09 Common Stock 10526 10526 D On May 9, 2016, the reporting person was granted an option to purchase 10,526 options of common stock. The performance criteria for this grant were met as of March 20, 2018 and the option shall vest in four (4) equal tranches on the first, second, third and fourth anniversaries of March 20, 2018 subject to continuous service with the Company as of each vesting date. CMO & EVP, Research & Development /s/ Jean Liu 2018-03-22